Fresenius Medical Care AG & Co. KGaA (1FME) Stock Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1FME Analyst Ratings

Moderate Sell

1 Buy

4 Hold

5 Sell

Based on 10 analysts giving stock ratings to

Fresenius

Medical Care AG & Co. KGaA

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1FME Stock 12 Month Forecast

Average Price Target

€44.11

▲(4.38% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Fresenius Medical Care AG & Co. KGaA in the last 3 months. The average price target is €44.11 with a high forecast of €54.50 and a low forecast of €36.00. The average price target represents a 4.38% change from the last price of €42.26.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"34":"€34","55":"€55","39.25":"€39.3","44.5":"€44.5","49.75":"€49.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":54.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€54.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€44.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€36.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[34,39.25,44.5,49.75,55],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.64,47.244615384615386,47.84923076923077,48.45384615384616,49.058461538461536,49.66307692307692,50.26769230769231,50.87230769230769,51.47692307692308,52.081538461538464,52.68615384615384,53.29076923076923,53.895384615384614,{"y":54.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.64,46.44538461538462,46.25076923076923,46.05615384615385,45.86153846153846,45.66692307692308,45.472307692307695,45.277692307692305,45.08307692307692,44.88846153846154,44.69384615384615,44.49923076923077,44.30461538461538,{"y":44.11,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,46.64,45.82153846153846,45.003076923076925,44.184615384615384,43.36615384615385,42.54769230769231,41.72923076923077,40.91076923076923,40.09230769230769,39.27384615384615,38.45538461538462,37.636923076923075,36.81846153846154,{"y":36,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.551,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":41.873,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":42.525,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":46.814,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":45.025,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":44.636,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":43.108,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":50.38,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":48.63,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":43.32,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":43.88,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":45.19,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":46.64,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€54.50

Average Price Target€44.11

Lowest Price Target€36.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Graham Doyle

UBS

€38

Sell

-10.08%

Downside

Reiterated

11/04/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from UBS

James Vane

Jefferies

€36

Sell

-14.81%

Downside

Reiterated

11/04/25

Jefferies Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

David Adlington

J.P. Morgan

€41.5

Sell

-1.80%

Downside

Reiterated

11/04/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan

Lisa Bedell Clive

Bernstein

€54.5

Hold

28.96%

Upside

Reiterated

10/20/25

Bernstein Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Falko Friedrichs

Deutsche Bank

€48

Hold

13.58%

Upside

Reiterated

10/20/25

Anna Ractliffe

Bank of America Securities

€50→€38

Sell

-10.08%

Downside

Downgraded

10/15/25

Bank of America Securities downgrades Fresenius Medical Care AG & Co. KGaA (0H9X) to a Sell

Robert Davies

Morgan Stanley

€46→€41

Sell

-2.98%

Downside

Reiterated

10/14/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from Morgan Stanley

Rosa Clinessa

TR | OpenAI - 4o

€48

Buy

13.58%

Upside

Reiterated

09/27/25

AI Generated ArticleAI Generated Article

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

08/15/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from DZ BANK AG

Hassan Al-Wakeel

Barclays

€50→€50.5

Hold

19.50%

Upside

Reiterated

08/07/25

Barclays Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Richard Felton

Goldman Sachs

€62→€60

Buy

41.98%

Upside

Reiterated

08/06/25

Goldman Sachs Keeps Their Buy Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Oliver Reinberg

Kepler Capital

€49

Hold

15.95%

Upside

Reiterated

08/05/25

Kepler Capital Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Victoria Lambert

Berenberg Bank

€55→€60

Buy

41.98%

Upside

Reiterated

06/24/25

Berenberg Bank Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Veronika Dubajova

Citi

€46.5→€52.5

Hold

24.23%

Upside

Reiterated

06/05/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Citi

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

05/12/25

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Graham Doyle

UBS

€38

Sell

-10.08%

Downside

Reiterated

11/04/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from UBS

James Vane

Jefferies

€36

Sell

-14.81%

Downside

Reiterated

11/04/25

Jefferies Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

David Adlington

J.P. Morgan

€41.5

Sell

-1.80%

Downside

Reiterated

11/04/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan

Lisa Bedell Clive

Bernstein

€54.5

Hold

28.96%

Upside

Reiterated

10/20/25

Bernstein Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Falko Friedrichs

Deutsche Bank

€48

Hold

13.58%

Upside

Reiterated

10/20/25

Anna Ractliffe

Bank of America Securities

€50→€38

Sell

-10.08%

Downside

Downgraded

10/15/25

Bank of America Securities downgrades Fresenius Medical Care AG & Co. KGaA (0H9X) to a Sell

Robert Davies

Morgan Stanley

€46→€41

Sell

-2.98%

Downside

Reiterated

10/14/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from Morgan Stanley

Rosa Clinessa

TR | OpenAI - 4o

€48

Buy

13.58%

Upside

Reiterated

09/27/25

AI Generated ArticleAI Generated Article

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

08/15/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from DZ BANK AG

Hassan Al-Wakeel

Barclays

€50→€50.5

Hold

19.50%

Upside

Reiterated

08/07/25

Barclays Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Richard Felton

Goldman Sachs

€62→€60

Buy

41.98%

Upside

Reiterated

08/06/25

Goldman Sachs Keeps Their Buy Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Oliver Reinberg

Kepler Capital

€49

Hold

15.95%

Upside

Reiterated

08/05/25

Kepler Capital Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Victoria Lambert

Berenberg Bank

€55→€60

Buy

41.98%

Upside

Reiterated

06/24/25

Berenberg Bank Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Veronika Dubajova

Citi

€46.5→€52.5

Hold

24.23%

Upside

Reiterated

06/05/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Citi

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

05/12/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

1 Month

xxx

Success Rate

14/23 ratings generated profit

Average Return

+3.80%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.87% of your transactions generating a profit, with an average return of +3.80% per trade.

3 Months

xxx

Success Rate

16/23 ratings generated profit

Average Return

+6.00%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.57% of your transactions generating a profit, with an average return of +6.00% per trade.

1 Year

Victoria LambertBerenberg Bank

Success Rate

18/23 ratings generated profit

Average Return

+11.85%

reiterated a buy rating 5 months ago

Copying Victoria Lambert's trades and holding each position for 1 Year would result in 78.26% of your transactions generating a profit, with an average return of +11.85% per trade.

2 Years

xxx

Success Rate

20/23 ratings generated profit

Average Return

+24.16%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 86.96% of your transactions generating a profit, with an average return of +24.16% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1FME Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1FME has received 2 Buy Ratings, 3 Hold Ratings, and 11 Sell Ratings. 1FME average Analyst price target in the past 3 months is 44.11.

Each month's total comprises the sum of three months' worth of ratings.

1FME Financial Forecast

1FME Earnings Forecast

Next quarter’s earnings estimate for 1FME is €1.02 with a range of €0.61 to €1.44. The previous quarter’s EPS was €1.10. 1FME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 1FME has Preformed in-line its overall industry.

1FME Sales Forecast

Next quarter’s sales forecast for 1FME is €4.78B with a range of €3.87B to €5.10B. The previous quarter’s sales results were €4.88B. 1FME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 1FME has Preformed in-line its overall industry.

1FME Stock Forecast FAQ

What is IT:1FME’s average 12-month price target, according to analysts?

Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is 44.11.

What is IT:1FME’s upside potential, based on the analysts’ average price target?

Fresenius Medical Care AG & Co. KGaA has 4.38% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?

Fresenius Medical Care AG & Co. KGaA has a consensus rating of Moderate Sell, which is based on 1 buy ratings, 4 hold ratings and 5 sell ratings.

What is Fresenius Medical Care AG & Co. KGaA’s share price target?

The average share price target for Fresenius Medical Care AG & Co. KGaA is 44.11. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €54.50 ,and the lowest forecast is €36.00. The average share price target represents 4.38% Increase from the current price of €42.26.

What do analysts say about Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Fresenius Medical Care AG & Co. KGaA?

To buy shares of IT:1FME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Fresenius Medical Care AG & Co. KGaA (1FME) Stock Forecast & Price Target

1FME Analyst Ratings

1FME Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

1FME Analyst Recommendation Trends

1FME Financial Forecast

1FME Earnings Forecast

1FME Sales Forecast

1FME Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts